Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience

PURPOSE: High-dose-rate brachytherapy (HDR-BT) delivered in a single fraction as monotherapy is a potential treatment modality for low- and intermediate-risk prostate cancer (LIR-PC); however, outcome data with this technique remain limited. Here we describe our institutional HDR monotherapy experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Justin M., Gabani, Prashant, Sanders, Max, Chundury, Anupama, Altman, Michael, Garcia-Ramirez, Jose, Li, Harold, Zoberi, Jacqueline E., Baumann, Brian C., Gay, Hiram A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854868/
https://www.ncbi.nlm.nih.gov/pubmed/31749847
http://dx.doi.org/10.5114/jcb.2019.89367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854868/
https://www.ncbi.nlm.nih.gov/pubmed/31749847
http://dx.doi.org/10.5114/jcb.2019.89367

Ejemplares similares